Standardization of flow cytometric minimal residual disease assessment in international clinical trials - a feasibility study from the European Myeloma Network - Hofste op Bruinink, Davine; Oliva, Stefania; Rihova, Lucie; Schmitz, Alexander; Gilestro, Milena; Te Marvelde, Jeroen; Kralova, Romana; Høholt, Helle; Broijl, Annemiek; Johnsen, Hans Erik; Hajek, Roman; Boccadoro, Mario; et al. (Haematologica, 2020)
Keywords: reziduální nádor; Flow Cytometry; Multiple Myeloma; Reference Standards; lidé; Feasibility Studies; průtoková cytometrie; referenční standardy; mnohočetný myelom; Humans; studie proveditelnosti; Neoplasm, Residual